TY - JOUR
T1 - Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture
AU - Giobbe, Giovanni Giuseppe
AU - Crowley, Claire
AU - Luni, Camilla
AU - Campinoti, Sara
AU - Khedr, Moustafa
AU - Kretzschmar, Kai
AU - De Santis, Martina Maria
AU - Zambaiti, Elisa
AU - Michielin, Federica
AU - Meran, Laween
AU - Hu, Qianjiang
AU - van Son, Gijs
AU - Urbani, Luca
AU - Manfredi, Anna
AU - Giomo, Monica
AU - Eaton, Simon
AU - Cacchiarelli, Davide
AU - Li, Vivian S W
AU - Clevers, Hans
AU - Bonfanti, Paola
AU - Elvassore, Nicola
AU - De Coppi, Paolo
PY - 2019/12/11
Y1 - 2019/12/11
N2 - Organoids have extensive therapeutic potential and are increasingly opening up new avenues within regenerative medicine. However, their clinical application is greatly limited by the lack of effective GMP-compliant systems for organoid expansion in culture. Here, we envisage that the use of extracellular matrix (ECM) hydrogels derived from decellularized tissues (DT) can provide an environment capable of directing cell growth. These gels possess the biochemical signature of tissue-specific ECM and have the potential for clinical translation. Gels from decellularized porcine small intestine (SI) mucosa/submucosa enable formation and growth of endoderm-derived human organoids, such as gastric, hepatic, pancreatic, and SI. ECM gels can be used as a tool for direct human organoid derivation, for cell growth with a stable transcriptomic signature, and for in vivo organoid delivery. The development of these ECM-derived hydrogels opens up the potential for human organoids to be used clinically.
AB - Organoids have extensive therapeutic potential and are increasingly opening up new avenues within regenerative medicine. However, their clinical application is greatly limited by the lack of effective GMP-compliant systems for organoid expansion in culture. Here, we envisage that the use of extracellular matrix (ECM) hydrogels derived from decellularized tissues (DT) can provide an environment capable of directing cell growth. These gels possess the biochemical signature of tissue-specific ECM and have the potential for clinical translation. Gels from decellularized porcine small intestine (SI) mucosa/submucosa enable formation and growth of endoderm-derived human organoids, such as gastric, hepatic, pancreatic, and SI. ECM gels can be used as a tool for direct human organoid derivation, for cell growth with a stable transcriptomic signature, and for in vivo organoid delivery. The development of these ECM-derived hydrogels opens up the potential for human organoids to be used clinically.
U2 - 10.1038/s41467-019-13605-4
DO - 10.1038/s41467-019-13605-4
M3 - Article
C2 - 31827102
SN - 2041-1723
VL - 10
SP - 5658
JO - Nature Communications
JF - Nature Communications
IS - 1
ER -